madman
Super Moderator
Must listen for anyone interested in fertility especially when using exogenous T!
* Why lab work and semen analysis interpretation require true infertility expertise
In this exciting episode of Fertility and Other F Words, Dr. Amy Pearlman and Dr. Larry Lipshultz are joined by two leaders in male reproductive medicine: Dr. Blair T. Stocks and Dr. Taylor Kohn.
Dr. Stocks and Kohn are Assistant Professors of Urology in the Division of Male Reproductive Medicine and Surgery at Baylor College of Medicine. Both specialize in the evaluation and treatment of men presenting with infertility.
Together, we walk through what a thorough male fertility evaluation actually looks like—from history and physical exam to lab work and imaging—and discuss cutting-edge research and innovative techniques being used to better understand why some men present with infertility and how sperm may still be found in men who’ve been told they have none.
This episode dives deep into:
* How male fertility is evaluated in real clinical practice
* Why lab work and semen analysis interpretation require true infertility expertise
* What azoospermia really means—and why it doesn’t always mean “no options”
* Emerging technologies helping specialists find sperm with greater precision
Key Takeaways
Semen analysis is an important metric of a man’s health. At-home semen analysis testing can be used as a screening tool.
In-office semen analysis and hormonal blood work are core parts of the evaluation and blood work may include:
- Total testosterone
- Free testosterone
- FSH
- LH
- Inhibin B
- Anti-Müllerian Hormone (AMH)
- 17-hydroxyprogesterone (17-OH progesterone)
- Prolactin
- Estradiol
* Interpretation of semen analysis and lab results should be done by an expert in male infertility.
* Men told they have azoospermia (no sperm in the ejaculate) may still have additional options.
* There are currently no FDA-approved medications for male infertility
* A healthy lifestyle—nutrition, movement, and overall wellness—matters for sperm health
Innovative Research Highlighted
Dr. Taylor Kohn is using high-frequency ultrasound to identify areas of the testicle more likely to contain sperm by visualizing dilated seminiferous tubules—helping guide sperm extraction procedures with greater precision and potentially less invasiveness.
Dr. Blair Stocks is using flow cytometry to determine whether men told they have “no sperm” truly have none, allowing rapid identification of rare sperm cells that may otherwise be missed.
* Why lab work and semen analysis interpretation require true infertility expertise
In this exciting episode of Fertility and Other F Words, Dr. Amy Pearlman and Dr. Larry Lipshultz are joined by two leaders in male reproductive medicine: Dr. Blair T. Stocks and Dr. Taylor Kohn.
Dr. Stocks and Kohn are Assistant Professors of Urology in the Division of Male Reproductive Medicine and Surgery at Baylor College of Medicine. Both specialize in the evaluation and treatment of men presenting with infertility.
Together, we walk through what a thorough male fertility evaluation actually looks like—from history and physical exam to lab work and imaging—and discuss cutting-edge research and innovative techniques being used to better understand why some men present with infertility and how sperm may still be found in men who’ve been told they have none.
This episode dives deep into:
* How male fertility is evaluated in real clinical practice
* Why lab work and semen analysis interpretation require true infertility expertise
* What azoospermia really means—and why it doesn’t always mean “no options”
* Emerging technologies helping specialists find sperm with greater precision
Key Takeaways
Semen analysis is an important metric of a man’s health. At-home semen analysis testing can be used as a screening tool.
In-office semen analysis and hormonal blood work are core parts of the evaluation and blood work may include:
- Total testosterone
- Free testosterone
- FSH
- LH
- Inhibin B
- Anti-Müllerian Hormone (AMH)
- 17-hydroxyprogesterone (17-OH progesterone)
- Prolactin
- Estradiol
* Interpretation of semen analysis and lab results should be done by an expert in male infertility.
* Men told they have azoospermia (no sperm in the ejaculate) may still have additional options.
* There are currently no FDA-approved medications for male infertility
* A healthy lifestyle—nutrition, movement, and overall wellness—matters for sperm health
Innovative Research Highlighted
Dr. Taylor Kohn is using high-frequency ultrasound to identify areas of the testicle more likely to contain sperm by visualizing dilated seminiferous tubules—helping guide sperm extraction procedures with greater precision and potentially less invasiveness.
Dr. Blair Stocks is using flow cytometry to determine whether men told they have “no sperm” truly have none, allowing rapid identification of rare sperm cells that may otherwise be missed.
